Context-Dependent Associations Between Variation in Risk of Ischemic Heart Disease and Variation in the 5′ Promoter Region of the Apolipoprotein E Gene in Danish Women
暂无分享,去创建一个
Charles F. Sing | Anne Tybjærg-Hansen | Greg Dyson | J. Stengård | C. Sing | B. Nordestgaard | R. Frikke-Schmidt | A. Tybjærg‐Hansen | Jari H. Stengård | Ruth Frikke-Schmidt | Borge G. Nordestgaard | G. Dyson
[1] C. Clancy,et al. Comparative-effectiveness research--implications of the Federal Coordinating Council's report. , 2009, The New England journal of medicine.
[2] Børge G. Nordestgaard,et al. Modifications to the Patient Rule‐Induction Method that utilize non‐additive combinations of genetic and environmental effects to define partitions that predict ischemic heart disease , 2009, Genetic epidemiology.
[3] Peter Kraft,et al. Beyond odds ratios — communicating disease risk based on genetic profiles , 2009, Nature Reviews Genetics.
[4] V. Menon,et al. Status of women in cardiovascular clinical trials. , 2009, Arteriosclerosis, thrombosis, and vascular biology.
[5] Robert A. Hegele,et al. Plasma lipoproteins: genetic influences and clinical implications , 2009, Nature Reviews Genetics.
[6] John P A Ioannidis,et al. Prediction of Cardiovascular Disease Outcomes and Established Cardiovascular Risk Factors by Genome-Wide Association Markers , 2009, Circulation. Cardiovascular genetics.
[7] D. Newman. The statins in preventive cardiology. , 2009, The New England journal of medicine.
[8] K. Weiss. Tilting at Quixotic Trait Loci (QTL): An Evolutionary Perspective on Genetic Causation , 2008, Genetics.
[9] Anders Larsson,et al. Use of multiple biomarkers to improve the prediction of death from cardiovascular causes. , 2008, The New England journal of medicine.
[10] Philippa J Talmud,et al. Cardiovascular disease risk prediction using genetic information (gene scores): is it really informative? , 2008, Current opinion in lipidology.
[11] M. Dichgans,et al. Update on the genetics of stroke and cerebrovascular disease 2007. , 2008, Stroke.
[12] J. Stengård,et al. Variation in 5' Promoter Region of the APOE gene Contributes to Predicting Ischemic Heart Disease (IHD) in the Population at Large: the Copenhagen City Heart Study , 2007, Annals of human genetics.
[13] Børge G. Nordestgaard,et al. An application of the patient rule‐induction method for evaluating the contribution of the Apolipoprotein E and Lipoprotein Lipase genes to predicting ischemic heart disease , 2007, Genetic epidemiology.
[14] David M Herrington,et al. Relevance of Genetics and Genomics for Prevention and Treatment of Cardiovascular Disease: A Scientific Statement From the American Heart Association Council on Epidemiology and Prevention, the Stroke Council, and the Functional Genomics and Translational Biology Interdisciplinary Working Group , 2007, Circulation.
[15] D. Grobbee,et al. Role of Genetic Analyses in Cardiology: Part II: Heritability Estimation for Gene Searching in Multifactorial Diseases , 2006, Circulation.
[16] E. Boerwinkle,et al. Contribution of regulatory and structural variations in APOE to predicting dyslipidemia Published, JLR Papers in Press, November 29, 2005. , 2006, Journal of Lipid Research.
[17] Francis S Collins,et al. Realizing the promise of genomics in biomedical research. , 2005, JAMA.
[18] Dana C Crawford,et al. The patterns of natural variation in human genes. , 2005, Annual review of genomics and human genetics.
[19] H. Markus,et al. Update on genetics of stroke and cerebrovascular disease 2005. , 2005, Stroke.
[20] D. Steinberg. Thematic review series: The Pathogenesis of Atherosclerosis. An interpretive history of the cholesterol controversy: part I Published, JLR Papers in Press, April 21, 2004. DOI 10.1194/jlr.R400003-JLR200 11 Based in part on The Cholesterol Wars, a book in preparation. , 2004, Journal of Lipid Research.
[21] C. Sing,et al. Gender- and age-specific contributions of additional DNA sequence variation in the 5′ regulatory region of the APOE gene to prediction of measures of lipid metabolism , 2004, Human Genetics.
[22] R. D'Agostino,et al. Concept and usefulness of cardiovascular risk profiles. , 2004, American heart journal.
[23] E. Barrett-Connor,et al. Women and heart disease: the role of diabetes and hyperglycemia. , 2004, Archives of internal medicine.
[24] Andrew G. Clark,et al. The effects of scale: variation in the APOA1/C3/A4/A5 gene cluster , 2004, Human Genetics.
[25] J. Lambert,et al. The allelic modulation of apolipoprotein E expression by oestrogen: potential relevance for Alzheimer’s disease , 2004, Journal of Medical Genetics.
[26] J. Stengård,et al. Genes, Environment, and Cardiovascular Disease , 2003, Arteriosclerosis, thrombosis, and vascular biology.
[27] J. Stengård,et al. Utility of the Arg/Gln polymorphism of the factor VII (FVII) gene, serum lipid levels and body mass index in the prediction of the FVII:C and FVII:Ag in North Karelia; a cross-sectional and prospective study , 2001, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.
[28] R. Marshall. The use of classification and regression trees in clinical epidemiology. , 2001, Journal of clinical epidemiology.
[29] P. Schnohr,et al. Context-dependent and invariant associations between lipids, lipoproteins, and apolipoproteins and apolipoprotein E genotype. , 2000, Journal of lipid research.
[30] E. Boerwinkle,et al. Sequence diversity and large-scale typing of SNPs in the human apolipoprotein E gene. , 2000, Genome research.
[31] E. Boerwinkle,et al. Apolipoprotein E variation at the sequence haplotype level: implications for the origin and maintenance of a major human polymorphism. , 2000, American journal of human genetics.
[32] D. Cheek,et al. Women and cardiovascular disease. , 2000, The Nursing clinics of North America.
[33] J. Stengård,et al. Utility of the predictors of coronary heart disease mortality in a longitudinal study of elderly Finnish men aged 65 to 84 years is dependent on context defined by Apo E genotype and area of residence , 1999, Clinical genetics.
[34] L. Bernier,et al. Apolipoprotein E and atherosclerosis: insight from animal and human studies. , 1999, Clinica chimica acta; international journal of clinical chemistry.
[35] L. Shaffer,et al. Pure trisomy 10p involving an isochromosome 10p , 1999, Clinical genetics.
[36] Nicholas I. Fisher,et al. Bump hunting in high-dimensional data , 1999, Stat. Comput..
[37] D. Levy,et al. Prediction of coronary heart disease using risk factor categories. , 1998, Circulation.
[38] D A Bloch,et al. Recursive partitioning for the identification of disease risk subgroups: a case-control study of subarachnoid hemorrhage. , 1998, Journal of clinical epidemiology.
[39] P. Wilson,et al. Apolipoprotein E alleles and risk of coronary disease. A meta-analysis. , 1996, Arteriosclerosis, thrombosis, and vascular biology.
[40] P A Wolf,et al. Apolipoprotein E alleles, dyslipidemia, and coronary heart disease. The Framingham Offspring Study. , 1994, JAMA.
[41] C. Sing,et al. Effects of polymorphisms in apolipoproteins E, A-IV, and H on quantitative traits related to risk for cardiovascular disease. , 1991, Arteriosclerosis and thrombosis : a journal of vascular biology.
[42] D. T. Vernier,et al. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. , 1990, Journal of lipid research.
[43] C. Sing,et al. Role of the apolipoprotein E polymorphism in determining normal plasma lipid and lipoprotein variation. , 1985, American journal of human genetics.
[44] William H. Barker,et al. CLINICAL EPIDEMIOLOGY: THE ESSENTIALS. , 1984 .
[45] W. Kannel,et al. Multiple risk functions for predicting coronary heart disease: the concept, accuracy, and application. , 1982, American heart journal.
[46] James A Brink,et al. Traditional clinical risk assessment tools do not accurately predict coronary atherosclerotic plaque burden: a CT angiography study. , 2009, AJR. American journal of roentgenology.
[47] C. Sing,et al. Subsets of SNPs define rare genotype classes that predict ischemic heart disease , 2006, Human Genetics.
[48] R. Lewontin,et al. The analysis of variance and the analysis of causes. 1974. , 2006, International journal of epidemiology.
[49] D. Noble. Music of life : biology beyond the genome , 2006 .
[50] B. Nordestgaard,et al. The Copenhagen City Heart Study , 2003 .
[51] Antony M. Jose,et al. The Triple Helix: Gene, Organism, and Environment , 2001, The Yale Journal of Biology and Medicine.
[52] Y. Zhi. Apolipoprotein E Alleles, Dyslipidemia,and Coronary Heart Disease , 2001 .
[53] H. Mcgill. Atherosclerosis: problems in endpoints for genetic analysis. , 1979, Progress in clinical and biological research.
[54] H. D. Brunk,et al. Computer-Aided Prognosis , 1975 .